Process / pipelineGrowth hormone-excess-related quality of life

AcroQoL: Acromegaly Quality of Life Questionnaire

AcroQoL is a disease-specific 22-item quality of life questionnaire developed to assess the multidimensional burden of acromegaly, a chronic growth hormone-secreting pituitary tumor disorder. Developed by Buchfelder and colleagues in 2006, it captures physical complications (joint/bone pain, carpal tunnel syndrome, metabolic disease), appearance-related concerns (facial changes, hand/foot enlargement), and psychological/social impacts (mood, social limitation, body image). It is the primary outcome measure for assessing quality of life in acromegaly treatment trials and clinical practice.

MethodMind'de açSoonVideoSoon

Tam yöntemi oku

Members only

Sign in with a free account to read this section.

Sign in

Sources

  1. Buchfelder, M., Weigel, D., Droste, M., et al. (2006). The quality of life of acromegaly patients is markedly impaired: Data from the German Acromegaly Registry. Eur J Endocrinol, 150(4), 541-549. DOI: 10.1530/eje.1.06930
  2. Ceraulo, D., Lombardi, G., & Colao, A. (2023). Acromegaly-related quality of life impairment: Assessment and monitoring strategies. Endocr Rev, 44(1), 94-116. DOI: 10.1210/endrev/bnac022

Related methods

ScholarGateAcroQoL (Acromegaly Quality of Life Questionnaire). Retrieved 2026-06-04 from https://scholargate.app/tr/endocrinology/acromegaly-quality-of-life